ZheMin Zhou

ZheMin Zhou


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2012 in Microbial Cell Factories
Verified
Journal Article
Open access
PDF file
JGJin-Song Gong
Jin-Song Gong
ZLZhen-Ming Lu
Zhen-Ming Lu
HLHeng Li
Heng Li
JSJin-Song Shi
Jin-Song Shi
ZZZheMin Zhou
ZheMin Zhou
ZXZheng-Hong Xu
Zheng-Hong Xu
Over the past decades, nitrilases have drawn considerable attention because of their application in nitrile degradation as prominent biocatalysts. Nitrilases are derived from bacteria, filamentous fungi, yeasts, and plants. In-depth investigations on their natural sources function mechanisms, enzyme structure, screening pathways, and biocatalytic properties have been conducted. Moreover, the immobilization, purification, gene cloning and modifications of nitrilase have been dwelt upon. Some nitrilases are used commercially as biofactories for carboxylic acids production, waste treatment, and surface modification. This critical review summarizes the current status of nitrilase research, and discusses a number of challenges and significant attempts in its further development. Nitrilase is a significant and promising biocatalyst for catalytic applications.

10 September 2018 in World Journal of Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
qiao linqiao lin
qiao lin
LHLaichuang Han
Laichuang Han
FSFeiya Suo
Feiya Suo
ZLZhongmei Liu
Zhongmei Liu
LZLi Zhou
Li Zhou
ZZZheMin Zhou
ZheMin Zhou

20 June 2013 in The FEBS Journal
Verified
Journal Article
Open access
PDF file
WCWenjing Cui
Wenjing Cui
SZShuai Zhang
Shuai Zhang
CSChangliang Shan
Changliang Shan
LZLi Zhou
Li Zhou
ZZZheMin Zhou
ZheMin Zhou
MicroRNAs are small, highly conserved, non‐coding RNAs that regulate gene expression of target mRNAs through cleavage or translational inhibition, and are widely involved in carcinogenesis and cancer development. In this study, the expression profile of microRNA‐133a (miR‐133a) was examined in breast cancer cells and breast cancer tissues. The results showed that expression of miR‐133a in both breast cancer cells and breast cancer tissues was significantly down‐regulated. Over‐expression of miR‐133a in tumor cells arrested the cell cycle by drastically decreasing the G2/S phase and retarded the newly synthesized DNA, suggesting a regulatory role for miR‐133a in proliferation of breast cancer cells. Bioinformatics prediction showed that epidermal growth factor receptor (EGFR) is a potential target for miR‐133a. A dual luciferase reporter gene assay showed that miR‐133a bound to the 3′ UTR of EGFR but not a mutated 3′ UTR, thereby down‐regulating the protein expression level. Accordingly, we found that expression of EGFR protein decreased with increased expression of miR‐133a in MCF‐7 and MDA‐MB‐231 cells. Over‐expression of miR‐133a in breast cancer cells resulted in suppression of the level of phosphorylated Akt protein (p‐Akt) and inhibition of p‐Akt nuclear translocation. These results demonstrate that miR‐133a, which may act as a tumor suppressor in breast cancer, regulates the cell cycle and proliferation in tumorigenesis by targeting EGFR through the downstream signal molecule Akt. Overall, these results show that miR‐133a may be used as biomarker and/or therapeutic target for diagnosis and therapy of breast cancer.

1 May 2016 in New Biotechnology
Verified
Journal Article
Closed access
CGChengran Guan
Chengran Guan
qiao linqiao lin
qiao lin
JCJintao Cheng
Jintao Cheng
RLRui Liu
Rui Liu
ZLZhongmei Liu
Zhongmei Liu
ZZZheMin Zhou
ZheMin Zhou

21 September 2015 in Microbial Cell Factories
Verified
Journal Article
Open access
PDF file
CGChengran Guan
Chengran Guan
qiao linqiao lin
qiao lin
JCJintao Cheng
Jintao Cheng
LZLi Zhou
Li Zhou
JGJunling Guo
Junling Guo
ZZZheMin Zhou
ZheMin Zhou
Bacillus subtilis is an all-important Gram-positive bacterium of valuable biotechnological utility that has been widely used to over-produce industrially and pharmaceutically relevant proteins. There are a variety of expression systems in terms of types of transcriptional patterns, among which the auto-inducible and growth-phase-dependent promoters are gaining increasing favor due to their inducer-independent feature, allowing for the potential to industrially scale-up. To expand the applicability of the auto-inducible expression system, a novel auto-regulatory expression system coupled with cell density was constructed and developed in B. subtilis using the quorum-sensing related promoter srfA (PsrfA). The promoter of the srf operon was used to construct an expression plasmid with the green fluorescent protein (GFP) downstream of PsrfA. The expression displayed a cell-density-dependent pattern in that GFP had a fairly low expression level at the early exponential stage and was highly expressed at the late exponential as well as the stationary stages. Moreover, the recombinant system had a similar expression pattern in wild-type B. subtilis 168, WB600, and WB800, as well as in B. subtilis 168 derivative strain 1681, with the complete deletion of PsrfA, indicating the excellent compatibility of this system. Noticeably, the expression strength of PsrfA was enhanced by optimizing the −10 and −35 core sequence by substituting both sequences with consensus sequences. Importantly, the expression pattern was successfully developed in an auto-regulatory cell-density coupling system by the simple addition of glucose in which GFP could not be strongly expressed until glucose was depleted, resulting in a greater amount of the GFP product and increased cell density. The expression system was eventually tested by the successful over-production of aminopeptidase to a desired level. The auto-regulatory cell density coupling system that is mediated by PsrfA is a novel expression system that has an expression pattern that is split between cell-growth and over-expression, leading to an increase in cell density and elevating the overall expression levels of heterologously expressed proteins. The broad applicability of this system and inducer-free expression property in B. subtilis facilitate the industrial scale-up and medical applications for the over-production of a variety of desired proteins.

24 April 2020 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
PDF file
ZCZhongyi Cheng
Zhongyi Cheng
YXYuanyuan Xia
Yuanyuan Xia
ZZZheMin Zhou
ZheMin Zhou
Nitrile hydratase (NHase, EC 4.2.1.84) is one type of metalloenzyme participating in the biotransformation of nitriles into amides. Given its catalytic specificity in amide production and eco-friendliness, NHase has overwhelmed its chemical counterpart during the past few decades. However, unclear catalytic mechanism, low thermostablity, and narrow substrate specificity limit the further application of NHase. During the past few years, numerous studies on the theoretical and industrial aspects of NHase have advanced the development of this green catalyst. This review critically focuses on NHase research from recent years, including the natural distribution, gene types, posttranslational modifications, expression, proposed catalytic mechanism, biochemical properties, and potential applications of NHase. The developments of NHase described here are not only useful for further application of NHase, but also beneficial for the development of the fields of biocatalysis and biotransformation.